- Home
- STRO vs VATE Comparison
STRO vs VATE Comparison
Compare STRO & VATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- VATE
- Stock Information
- Founded
- STRO 2003
- VATE 1994
- Country
- STRO United States
- VATE United States
- Employees
- STRO N/A
- VATE N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- VATE Metal Fabrications
- Sector
- STRO Health Care
- VATE Industrials
- Exchange
- STRO Nasdaq
- VATE Nasdaq
- Market Cap
- STRO 74.3M
- VATE 65.1M
- IPO Year
- STRO 2018
- VATE 1996
- Fundamental
- Price
- STRO $0.89
- VATE $4.75
- Analyst Decision
- STRO Hold
- VATE
- Analyst Count
- STRO 7
- VATE 0
- Target Price
- STRO $1.97
- VATE N/A
- AVG Volume (30 Days)
- STRO 598.8K
- VATE 27.4K
- Earning Date
- STRO 11-12-2025
- VATE 11-05-2025
- Dividend Yield
- STRO N/A
- VATE N/A
- EPS Growth
- STRO N/A
- VATE N/A
- EPS
- STRO N/A
- VATE N/A
- Revenue
- STRO $104,473,000.00
- VATE $995,000,000.00
- Revenue This Year
- STRO $65.42
- VATE N/A
- Revenue Next Year
- STRO N/A
- VATE N/A
- P/E Ratio
- STRO N/A
- VATE N/A
- Revenue Growth
- STRO N/A
- VATE N/A
- 52 Week Low
- STRO $0.52
- VATE $3.25
- 52 Week High
- STRO $4.80
- VATE $13.79
- Technical
- Relative Strength Index (RSI)
- STRO 48.54
- VATE 42.17
- Support Level
- STRO $0.85
- VATE $4.60
- Resistance Level
- STRO $1.01
- VATE $5.25
- Average True Range (ATR)
- STRO 0.09
- VATE 0.43
- MACD
- STRO -0.01
- VATE -0.04
- Stochastic Oscillator
- STRO 16.63
- VATE 13.39
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.